Al-Modawat Specialized Medical Company (9594) Fair Value & Analysis
Healthcare · SA · Market cap 374M SAR
Fair value as of: Aug 1, 2026
From 14 valuation models · updated today
Share price +34.9% over the past month.
Price vs Fair Value (12 months)
12‑month range 3.11 SAR – 972,709 SAR · fair‑value band 3.39 SAR – 6.03 SAR · the 5.25 SAR price screens above the 4.53 SAR fair value. As of Aug 1, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Al-Modawat Specialized Medical Company (9594) currently trades at 5.25 SAR, while our model-based Fair Value estimate is 4.53 SAR, implying the stock looks roughly 13.7% overvalued today. We read business quality at 39/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Al-Modawat Specialized Medical Company generated revenue of 128M SAR at a net margin of 12.8%. Revenue grew 21.7% year over year. It earns a return on equity of 18.8%. The stock trades on a trailing P/E of 22.8. Fundamentals as of Aug 1, 2026
Our scenario range runs from 3.39 SAR (bear case) to 6.03 SAR (bull case); at 5.25 SAR, the current price sits within that range. For context, the median of 10 Healthcare peers we cover trades at -11% fair-value upside, at -14%, 9594 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 1, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Al-Modawat Specialized Medical Company operates a general hospital in the Kingdom of Saudi Arabia. The company was founded in 2014 and is headquartered in Muhayil, Saudi Arabia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Al-Modawat Specialized Medical Company reported revenue of 122M SAR in FY2025 versus 40.8M SAR in FY2021, a compound +31.4%/yr. Reported net income was 19.0M SAR in FY2025.
Is 9594 fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 1, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$96.00 | R$25.67 | -73% |
| Fresenius SE FRE | €36.27 | €22.73 | -37% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.76 SGD | 1.28 SGD | -54% |
| Tenet Healthcare Corporation THC | $162.06 | $282.55 | +74% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
| DaVita Inc DVAI34 | R$1,030 | R$1,096 | +7% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,489 | ₹2,128 | -75% |
| Fresenius Medical Care AG FMSC34 | R$112.00 | R$164.58 | +47% |
| Aier Eye Hospital Group 300015 | ¥8.55 | ¥7.64 | -11% |
Compare Al-Modawat Specialized Medical Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Al-Modawat Specialized Medical Company (9594) overvalued or undervalued?
What is the fair value of 9594?
What is the quality score of 9594?
What is the revenue of Al-Modawat Specialized Medical Company (9594)?
What is the net profit margin of 9594?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Al-Modawat Specialized Medical Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.